期刊
ACS MEDICINAL CHEMISTRY LETTERS
卷 3, 期 2, 页码 123-128出版社
AMER CHEMICAL SOC
DOI: 10.1021/ml200249h
关键词
affinity selection-mass spectrometry (AS-MS); Automated Ligand Identification System (ALIS); CHK1 protein kinase; structure-based drug design; thiazole-4-carboxamide
A novel series of CHK1 inhibitors with a distinctive hinge binding mode, exemplified by 2-aryl-N-(2-(piperazin-1-yl)phenyl)thiazole-4-carboxamide, was discovered through high-throughput screening using the affinity selection-mass spectrometry (AS-MS)-based Automated Ligand Identification System (ALIS) platform. Structure-based ligand design and optimization led to significant improvements in potency to the single digit nanomolar range and hundred-fold selectivity against CDK2.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据